Scientific Program Partner
Meeting agenda created in conjunction with The Antibody Society.
Accelerating Tomorrow's Antibody Therapeutics Today
The Summit of Antibody Science and Your Path to Commercial Success
Antibodies • Proteins • Bispecifics • Multispecifics • ADCs
What’s Waiting for You in Sunny San Diego
+
World-Class Speaker Presentations
+
Antibody Scientists & Executives
+
Leading Industry Exhibitors
+
Scientific Posters Highlighting Breakthrough Research
Discover the Keynote Speakers Driving Antibody Innovation
Where Antibody Breakthroughs Begin
Get an inside look at this year’s agenda - packed with world-class speakers and forward-thinking research across antibody engineering and therapeutic development.
Novel Bispecific and Multi-specific Antibodies
Explore advanced multispecific formats to overcome therapeutic limitations
Case studies on bispecific ADCs and conditional activation platforms
Engineering strategies for glycan targeting, avidity, and stability
Antibody Therapeutics in Emerging Disease Areas: Non-Oncology
Novel antibodies for fibrosis, cardiovascular disease, and CNS delivery
Innovative biologics targeting innate and adaptive immune pathways
Translating discoveries into therapies for complex non-oncology indications
Innovative Engineering for Cell Engagers
AI-driven design and next-gen T-cell engager platforms
Strategies to improve potency, selectivity, and safety in immunotherapy
Novel conditional engagers and dual-binding antibodies in cancer therapy
Antibody & Protein Therapeutics in Inflammation, Autoimmunity and Allergy
Breakthroughs in cell depletion strategies for autoimmune diseases
Next-gen cytokine blockers and trispecific antibodies for inflammation
Novel approaches to allergy treatment, from IgE cleavage to immune modulation
Emerging In Vitro Approaches to Antibody Discovery
Cutting-edge display technologies and high-throughput screening platforms
Computational and AI-driven antibody engineering for speed and precision
Case studies on de novo antibody design and rapid evolution systems
Engineering Innovative Formats & Scaffolds
Nanobody and knottin engineering for novel therapeutic applications
Advances in GPCR-targeting formats and allosteric modulators
Overcoming immunogenicity challenges with new scaffold architectures
Advanced In Vivo Antibody Discovery
Leveraging animal models and immune organoids for breakthrough discovery
In vivo screening approaches for CNS delivery and biodistribution
Strategies to accelerate discovery of antibodies against infectious diseases
Antibody Drug Conjugates - Novel Payloads and Engineering
Dual-payload ADCs for enhanced efficacy and resistance management
Site-specific conjugation techniques for stability and safety
Novel non-cytotoxic payloads and improved therapeutic index strategies
Engineering Considerations for Candidate Selection and Developability
Early risk mitigation for immunogenicity and chemical liabilities
ML-driven workflows for predictive developability optimization
High-throughput strategies for complex biologics like ADCs and bispecifics
Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Investor perspectives on value creation and biotech funding trends
Lessons from successful preclinical-to-clinic transitions
Strategic insights for commercialization and portfolio optimization
Enhanced Efficacy Through Fc Engineering
Fc modifications to optimize effector function and immune activation
Site-specific conjugation and glycoengineering breakthroughs
Translating Fc innovations into next-gen therapeutics
Novel Extracellular Protein Degraders & Beyond
Cutting-edge eTPD platforms for transmembrane and extracellular targets
Novel bispecific degrader technologies and conjugate strategies
Expanding the druggable proteome beyond traditional antibody modalities
The Science. The Networking. The Moments.
Last year set the stage - 2025 will raise the bar. Watch the 2024 highlights, then join us this December in San Diego for the world’s leading antibody engineering event.
Ways to Attend
Join the Antibody Event of the Year in San Diego!
Get ready for 4 days of breakthrough science, powerful networking, and cutting-edge innovation at Antibody Engineering & Therapeutics US. This is your chance to:
✔ Access exclusive insights from 135+ world-renowned speakers sharing never-before-seen data and real-world case studies.
✔ Connect with 75+ leading solution providers driving the next wave of antibody engineering and therapeutic development.
✔ Explore the entire antibody landscape - from discovery and design to clinical development and commercialization.
Whether you’re passionate about bispecifics, ADCs, AI-driven discovery, or next-gen formats, this is where the future of antibody therapeutics takes shape.
Join us in sunny San Diego or tune in virtually from anywhere!
Showcase Your Research – Add a Poster Presentation
When you register for an in-person or digital Main Conference Pass (or Main Conference + Workshop Pass), you’ll have the exclusive opportunity to elevate your experience by adding a poster presentation for just $199.
This is your chance to:
✔ Showcase your research to leading scientists and industry innovators
✔ Spark meaningful discussions and gain valuable feedback
✔ Expand your professional visibility within the global antibody community
Don’t miss this opportunity to amplify your presence and make an impact!
Partner with the World’s Leading Antibody Event
Seize the opportunity to connect with key decision-makers and industry pioneers shaping the future of antibody therapeutics. As a sponsor of Antibody Engineering & Therapeutics US, your brand will be front and center at the industry’s most influential event, giving you:
✔ Unparalleled access to top biopharma leaders and innovators
✔ Opportunities to showcase your solutions to an engaged audience actively seeking new technologies and partnerships
✔ Direct connections that accelerate your business growth in the antibody and protein therapeutics market
Don’t miss your chance to position your brand at the forefront of antibody innovation.
Get the Latest Updates on 2025 Antibody Events
About the Antibody Society
The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community.
Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee.
